National Health Investors, Inc. (NYSE:NHI) Receives Consensus Rating of "Moderate Buy" from Analysts

National Health Investors, Inc. (NYSE:NHI - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six analysts that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $76.33.

Several research analysts recently commented on the stock. Truist Financial lifted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 30th. Bank of America started coverage on National Health Investors in a research report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price objective for the company. StockNews.com lowered National Health Investors from a "buy" rating to a "hold" rating in a report on Tuesday, October 15th. Finally, Wells Fargo & Company cut National Health Investors from an "overweight" rating to an "equal weight" rating and increased their price objective for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st.

National Health Investors Trading Up 0.5 %

Shares of NYSE:NHI traded up $0.39 during mid-day trading on Friday, hitting $72.70. The stock had a trading volume of 299,585 shares, compared to its average volume of 199,209. National Health Investors has a 12-month low of $51.59 and a 12-month high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The company has a market cap of $3.30 billion, a PE ratio of 24.98, a P/E/G ratio of 4.87 and a beta of 1.04. The company's 50 day moving average is $77.01 and its 200-day moving average is $75.37.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analysts' expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the company earned $1.08 earnings per share. On average, sell-side analysts predict that National Health Investors will post 4.42 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.95%. National Health Investors's payout ratio is currently 123.71%.

Institutional Trading of National Health Investors

Institutional investors and hedge funds have recently bought and sold shares of the business. Zimmer Partners LP acquired a new stake in National Health Investors during the third quarter worth approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of National Health Investors by 332.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock worth $20,370,000 after purchasing an additional 186,238 shares during the period. Charles Schwab Investment Management Inc. raised its stake in National Health Investors by 17.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock valued at $71,651,000 after purchasing an additional 123,596 shares in the last quarter. Waterfront Capital Partners LLC bought a new stake in National Health Investors during the third quarter worth about $10,097,000. Finally, Lee Danner & Bass Inc. acquired a new stake in National Health Investors during the second quarter worth about $5,089,000. Institutional investors own 62.51% of the company's stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.